Molecule Details
| InChIKey | VCPMZDWBEWTGNW-UHFFFAOYSA-N |
|---|---|
| Compound Name | Z-160 |
| Canonical SMILES | O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.96 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12743 |
|---|---|
| Drug Name | Z-160 |
| CAS Number | 41332-24-5 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Z160 has been used in trials studying the treatment of Postherpetic Neuralgia and Lumbosacral Radiculopathy. |
Categories: Antiarrhythmic agents Benzene Derivatives Calcium Channel Blockers Calcium-Regulating Hormones and Agents Cardiovascular Agents Membrane Transport Modulators
Cross-references: BindingDB: 50461289 CHEMBL604710 ChemSpider: 4168662 PubChem:4988454 PubChem:347828933 ZINC: ZINC000020509316
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P54289 | CACNA2D1 | Voltage-dependent calcium channel subunit alpha-2/delta-1 | inhibitor | targets |